Operations have grown dramatically over the past 30 years. Awareness about the dangers of untreated obstructive sleep apnea has increased, and we have introduced new, highly innovative, product lines.

With over 8,000 employees and a presence in over 140 countries, the company has been pioneering new and innovative devices and treatments for sleep apnea, COPD and other chronic respiratory diseases. ResMed’s world-leading products and innovative solutions, improve the quality of life for millions of patients worldwide, reduce the impact of chronic disease and save healthcare costs.

ResMed founder Peter Farrell is Chairman of ResMed’s Board of Directors. His son Michael “Mick” Farrell, a ResMed employee for more than 15 years, has been CEO since 2013.

Resmed

Operations have grown dramatically over the past 30 years. Awareness about the dangers of untreated obstructive sleep apnea has increased, and we have introduced new, highly innovative, product lines.

With over 8,000 employees and a presence in over 140 countries, the company has been pioneering new and innovative devices and treatments for sleep apnea, COPD and other chronic respiratory diseases. ResMed’s world-leading products and innovative solutions, improve the quality of life for millions of patients worldwide, reduce the impact of chronic disease and save healthcare costs.

ResMed founder Peter Farrell is Chairman of ResMed’s Board of Directors. His son Michael “Mick” Farrell, a ResMed employee for more than 15 years, has been CEO since 2013.